These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 4147164

  • 21. Central transmitter involvement in LON-954-induced tremorogenesis.
    Coward DM, Doggett NS, Thomas JE.
    Neuropharmacology; 1977; 16(7-8):479-84. PubMed ID: 144244
    [No Abstract] [Full Text] [Related]

  • 22. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain.
    Leonard BE.
    Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855
    [No Abstract] [Full Text] [Related]

  • 23. The effect of hypoxia on monoamine synthesis, levels and metabolism in rat brain.
    Davis JN, Carlsson A.
    J Neurochem; 1973 Oct; 21(4):783-90. PubMed ID: 4148239
    [No Abstract] [Full Text] [Related]

  • 24. Antagonism of the acute electroencephalographic and behavioral effects of morphine in the rat by depletion of brain biogenic amines.
    Colasanti B, Khazan N.
    Neuropharmacology; 1973 May; 12(5):463-9. PubMed ID: 4267733
    [No Abstract] [Full Text] [Related]

  • 25. Actions of atropine, hemicholinium-3, and physostigmine on chlorpromazine-induced changes in rat brain monoamines.
    Bhatnagar SP.
    Can J Physiol Pharmacol; 1974 Jun; 52(3):500-7. PubMed ID: 4152758
    [No Abstract] [Full Text] [Related]

  • 26. Effect of yohimbine on brain monoamines: an in vivo study.
    Brannan T, Martinez-Tica J, Yahr MD.
    J Neural Transm Park Dis Dement Sect; 1991 Jun; 3(2):81-7. PubMed ID: 1716906
    [Abstract] [Full Text] [Related]

  • 27. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM, Yarbrough GG, Carter ME.
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract] [Full Text] [Related]

  • 28. Measurements of monoamine synthesis and turnover with special reference to 5-hydroxytryptamine.
    Carlsson A.
    Adv Biochem Psychopharmacol; 1974 May; 10():75-81. PubMed ID: 4152552
    [No Abstract] [Full Text] [Related]

  • 29. Role of serotoninergic and adrenergic mechanisms in the action of prominal.
    Nowakowska E, Godlewski J.
    Acta Physiol Pol; 1979 May; 30(5-6):581-7. PubMed ID: 93847
    [Abstract] [Full Text] [Related]

  • 30. Brain monoamine levels and E1 mouse convulsions.
    Hiramatsu M.
    Folia Psychiatr Neurol Jpn; 1981 May; 35(3):261-6. PubMed ID: 6173293
    [Abstract] [Full Text] [Related]

  • 31. The effects of 3- -dimethylaminopropyl-3-phenylphthalide (I.C.I. 53,165) on brain monoamines and their precursors.
    Leonard BE.
    Arch Int Pharmacodyn Ther; 1972 Sep; 199(1):94-107. PubMed ID: 5072195
    [No Abstract] [Full Text] [Related]

  • 32. Modification of electroshock convulsive responses and thresholds in neonatal rats after brain monoamine reduction.
    London ED, Buterbaugh GG.
    J Pharmacol Exp Ther; 1978 Jul; 206(1):81-90. PubMed ID: 307060
    [Abstract] [Full Text] [Related]

  • 33. [Central monoaminergic mechanisms and generalized convulsions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1976 Jul; 76(3):457-63. PubMed ID: 817551
    [No Abstract] [Full Text] [Related]

  • 34. Reversal by L-DOPA of the suppression of locomotor activity induced by inhibition of tyrosine-hydroxylase and DA-beta-hydroxylase in mice.
    Ahlenius S.
    Brain Res; 1974 Mar 29; 69(1):57-65. PubMed ID: 4150408
    [No Abstract] [Full Text] [Related]

  • 35. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ, Littleton JM, Oritz A, Brownlee G.
    Br J Pharmacol; 1973 Jun 29; 48(2):354P. PubMed ID: 4147432
    [No Abstract] [Full Text] [Related]

  • 36. Studies related to the cholinergic influence on the accumulation and disappearance of monoamines in rat brain.
    Bhatnagar SP.
    Can J Physiol Pharmacol; 1973 Dec 29; 51(12):893-9. PubMed ID: 4777240
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S, Bolle P, Modigh K.
    Endocrinology; 1979 Aug 29; 105(2):523-9. PubMed ID: 156637
    [Abstract] [Full Text] [Related]

  • 40. Paradoxical blockade by p-chlorophenylalanine of 5-hydroxytryptophan facilitatory actions on spinal reflexes.
    Taber CA, Anderson EG.
    J Pharmacol Exp Ther; 1973 Nov 29; 187(2):229-38. PubMed ID: 4356011
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.